Patrik Simko
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology.
Journal: International journal of molecular sciences
Published: March 31, 2026
ATP and major affective disorders: the involvement of P2X receptors in pathophysiology.
Journal: Purinergic signalling
Published: December 23, 2025
COST action CA22103 Net4Brain: Pan-European network advancing translational research in brain cancer.
Journal: Critical reviews in oncology/hematology
Published: December 04, 2025
The Potential of Selected Plants and Their Biologically Active Molecules in the Treatment of Depression and Anxiety Disorders.
Journal: International journal of molecular sciences
Published: January 07, 2025
Physiology-inspired bifocal fronto-parietal tACS for working memory enhancement.
Journal: Heliyon
Published: May 06, 2024
The First In Vivo Study Shows That Gyrophoric Acid Changes Behavior of Healthy Laboratory Rats.
Journal: International journal of molecular sciences
Published: April 12, 2024
Bioactive Compounds and Their Influence on Postnatal Neurogenesis.
Journal: International journal of molecular sciences
Published: October 05, 2023
Exploring the impact of intensified multiple session tDCS over the left DLPFC on brain function in MCI: a randomized control trial.
Journal: Scientific reports
Published: June 14, 2023
A Pilot Study on the Functional Stability of Phonation in EEG Bands After Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease.
Journal: International journal of neural systems
Published: April 29, 2023
Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders.
Journal: Pharmaceutics
Published: November 29, 2022
Repetitive transcranial magnetic stimulation for hypokinetic dysarthria in Parkinson's disease enhances white matter integrity of the auditory-motor loop.
Journal: European journal of neurology
Published: November 04, 2022
Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats.
Journal: Life (Basel, Switzerland)
Published: October 06, 2022
Last Updated: 09/26/2026